Capital Fund Management S.A. Intercept Pharmaceuticals, Inc. Call Options Transaction History

Capital Fund Management S.A.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 13, 2020	SELL	$46.7 - $92.04 $177,460 - $349,752	-3,800 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$48.35 - $118.68 $53,185 - $130,548	1,100 Added 40.74%	3,800 $239,000
Q4 2019 Feb 13, 2020	SELL	$57.36 - $124.1 $86,040 - $186,150	-1,500 Reduced 35.71%	2,700 $335,000
Q3 2019 Nov 13, 2019	SELL	$58.69 - $80.46 $52,821 - $72,414	-900 Reduced 17.65%	4,200 $279,000
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $451,299 - $650,505	5,100 New	5,100 $644,000
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $252,000 - $359,814	-4,200 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $748,624 - $954,950	-14,200 Reduced 77.17%	4,200 $258,000
Q4 2017 Feb 09, 2018	BUY	$58.2 - $72.76 $1.07 Million - $1.34 Million	18,400	18,400 $1.08 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.